Implementing digital interventions for co-occurring mental health and alcohol and other drug use problems in health and community settings: a study protocol for the eCliPSE cluster randomised controlled trial

在医疗和社区环境中实施针对合并精神健康问题和酒精及其他药物滥用问题的数字化干预措施:eCliPSE 整群随机对照试验的研究方案

阅读:2

Abstract

BACKGROUND: Mental health and alcohol and other drug use problems consistently dominate the top causes of disease burden in Australians. eHealth stands to be a key tool in addressing these issues but is not routinely well-integrated into service provision models. This study will evaluate the uptake of the digital ecosystem and website, eCliPSE [electronic Clinical Pathways to Service Excellence], developed to improve the symptoms of mental health and alcohol and other drug use problems in people experiencing comorbidity. It will compare two different implementation strategies designed to engage consumers and health services with the eCliPSE website. METHODS: A cluster randomised controlled trial involving participants from 30 Australian public mental health and alcohol and other drug use services and 8 private psychology services will be conducted across the 15 local health districts in NSW. Each district will be randomised to receive one of two interventions: a Direct-to-Consumer [DtC] Marketing Strategy, or the DtC strategy in addition to an Integrated Translation and Engagement Model [ITEM] of implementation developed by the research team. The effectiveness of each strategy in encouraging uptake of eCliPSE (number of registrations) will be evaluated and compared. Data will be collected using a combination of the eCliPSE website and social media analytics, quantitative surveys, ethnographic observation, document review and qualitative interviews. An economic evaluation will also estimate the cost-effectiveness of DtC + ITEM and budget impact of the strategies, if implemented across Australia. DISCUSSION: It is expected that the DtC marketing strategy will result in significant uptake of eCliPSE, that districts receiving DtC + ITEM will demonstrate significantly greater uptake of eCliPSE than those receiving DtC only, and that the combined strategy will be cost-effective compared to DtC alone. Findings from this study will inform future integration and upscaling of digital health tools into traditional service settings for mental health and alcohol and other drug use across Australia. TRIAL REGISTRATION: This trial is registered with the Australian New Zealand Clinical Trials Registry as: The eCliPSE Project: A 3-level cluster randomised controlled trial implementing evidence-based eHealth interventions for comorbid mental health and alcohol/other drug use problems into health and community settings. Registration number: ACTRN12622000333718. Registration date: 23rd of February 2022. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-025-25706-5.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。